XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. XTL is a public company, traded on the NASDAQ (NASDAQ:XTLB) and the Tel-Aviv Stock Exchange (TASE:XTLB.TA)